Accelerated Access Review

The Accelerated Access Review was an initiative commissioned by the government of the United Kingdom,^[1] working with the Department of Health. The Accelerated Access Review aimed to speed up access to innovative drugs, devices and diagnostics for NHS patients. The Accelerated Access Review was commissioned by the government in November 2014, and produced its final report in October 2016.^[2]^[3]

References

^ "Accelerated Access Review: final report". GOV.UK. Retrieved 10 September 2019.
^ McKee, Selina (24 October 2016). "Gov't publishes findings of Accelerated Access Review". www.pharmatimes.com. Retrieved 28 July 2017.
^ "Accelerated Access Review report released". www.nhsconfed.org. 1 November 2016. Retrieved 28 July 2017.

External links

Accelerated Access Review: final report, Gov.uk

This National Health Service-related article is a stub. You can help Wikipedia by expanding it.

[1] "Accelerated Access Review: final report". GOV.UK. Retrieved 10 September 2019.

[2] McKee, Selina (24 October 2016). "Gov't publishes findings of Accelerated Access Review". www.pharmatimes.com. Retrieved 28 July 2017.

[3] "Accelerated Access Review report released". www.nhsconfed.org. 1 November 2016. Retrieved 28 July 2017.

[1]

[2]

[3]